44 results
8-K
EX-99.1
IVVD
Invivyd Inc
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
, partially offset by an increase in commercial manufacturing costs of PEMGARDA and ongoing clinical trial costs associated with our CANOPY clinical … costs, partially offset by a decrease in legal and corporate governance costs.
Net Loss and Net Loss Share: Net loss was $198.6 million for the year
8-K
EX-99.1
l33qop1f
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-99.1
t3styof5nw9k buxe
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
EX-10.1
6zvhg27 o7
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
EX-99.1
oc5p215dkd sius6o
10 Aug 23
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
EX-99.1
71tyi0tw2457
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm
8-K
EX-10.1
41y hbp9353nuw
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
8-K
EX-99.1
i29tej5b
10 Nov 22
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
4:13pm
8-K
EX-10.1
aye 4aidcdj
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
10-K
8f1yy5yjlujrv
31 Mar 22
Annual report
8:18am